Posts Tagged ‘ovarian cancer’
Despite Barriers, Labs Starting to Report Suspected Cancer Risk Mutations Seen in Tumor Testing
Paired tumor/germline testing is far from standard practice in cancer care, but some experts in the field are advocating that when patients have their tumors genomically profiled to determine precision medicine options, that is an opportunity to also evaluate them for their inherited risks for cancers.
Read MorePersonalized Medicine in 2019: Options Increasing But Are They Reaching Patients?
In 2019, the field of personalized medicine continued to grow with the market launch of more than two dozen drugs targeting novel genomic alterations and numerous genetic tests to determine whether patients are at risk for serious diseases like cancer, and whether they are likely to respond to therapy.
Read MoreWhat to Know Before You Buy an At-Home Genetic Cancer Risk Test
At-home DNA testing kits may not be a good fit for answering medical questions. Here’s what experts want you to consider and a review of three popular tests.
Read MoreGenetic Testing Challenges in Oncology: False Positive After Testing at Pop-Up Booth
Precision Oncology News and My Gene Counsel have partnered to produce the “Genetic Testing Challenges in Oncology” series to highlight real-world issues that genetics experts and medical professionals are encountering as genetic tests are increasingly used in cancer care.
Read MoreWho Should Consider Genetic Counseling and Testing for Breast and Ovarian Cancer? Guidelines Have Expanded
BRCA-Related Breast and/or Ovarian Cancer syndrome, previously known as Hereditary Breast and Ovarian Cancer syndrome (HBOC), is a well-known hereditary cancer syndrome characterized by increased risk for breast, ovarian, prostate, and pancreatic cancers and possibly melanoma. Genetic counseling and testing can help individuals learn more about their cancer risks as well as their options for…
Read MoreMy Gene Counsel Weighs in on Large-Scale Multigene Panel Study of Hereditary Cancer Risk
Investigators at Ambry Genetics, the Mayo Clinic in Rochester, the University of Utah, and the University of California at Irvine have tapped into Ambry’s large collection of multigene panel test results to clarify hereditary cancer associations in high-risk patients — identifying gene-specific cancer associations they hope will inform future hereditary cancer test guidance.
Read More